These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3953428)

  • 1. Efficacy of verapamil in patients resistant to other antihypertensive therapy.
    Luna RL; Carrasco RM
    Am J Cardiol; 1986 Feb; 57(7):64D-68D. PubMed ID: 3953428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extent of baroreceptor resetting in response to sodium nitroprusside and verapamil.
    Salgado HC; Krieger EM
    Hypertension; 1988 Feb; 11(2 Pt 2):I121-5. PubMed ID: 3346046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in the functional level of baroreceptors under the action of verapamil in arterial hypertension].
    Luna RL; Arslanian L; de Souza EM; de Oliveira PS
    Arq Bras Cardiol; 1988 Oct; 51(4):297-303. PubMed ID: 3251456
    [No Abstract]   [Full Text] [Related]  

  • 4. [Verapamil in the treatment of severe rapid onset hypertension. Potentiation of hypotensive drugs and sensitization of pressoreceptors by serial infusion of verapamil].
    Carrasco RM; Ribeiro LC; Luna RL
    Arq Bras Cardiol; 1979 Feb; 32(2):129-33. PubMed ID: 464854
    [No Abstract]   [Full Text] [Related]  

  • 5. Verapamil and 24-hour ambulatory blood pressure monitoring in essential hypertension.
    Zachariah PK; Sheps SG; Schirger A; Spiekerman RE; O'Brien PC; Simpson KK
    Am J Cardiol; 1986 Feb; 57(7):74D-79D. PubMed ID: 3953429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verapamil versus hydrochlorothiazide in the treatment of hypertension: results of long term double blind comparative trial. Verapamil versus Diuretic (VERDI) Trial Research Group.
    Holzgreve H; Distler A; Michaelis J; Philipp T; Wellek S
    BMJ; 1989 Oct; 299(6704):881-6. PubMed ID: 2510877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of complete baroreceptor resetting in hypertension.
    Krieger EM
    Drugs; 1988; 35 Suppl 6():98-103. PubMed ID: 3042363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil].
    Widimský J; Dzúrik R
    Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intravenous infusion of verapamil in patients of severe hypertension.
    Verma SK; Dosi R; Kaushik SK; Bordia A
    J Postgrad Med; 1990 Jan; 36(1):5-8. PubMed ID: 2097358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of verapamil and trandolapril in the treatment of hypertension. Trandolapril Study Group.
    Messerli F; Frishman WH; Elliott WJ
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):322-7. PubMed ID: 9544873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new sustained-release formulation of verapamil in the treatment of hypertension.
    Midtbo KA; Hals O; Lauve O
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):125S-132S. PubMed ID: 3540222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short- and long-term treatment of mild to moderate hypertension with verapamil.
    Wicker P; Roudaut R; Gosse P; Dallocchio M
    Am J Cardiol; 1986 Feb; 57(7):83D-86D. PubMed ID: 3953430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of equal-weight oral dosages of verapamil hydrochloride and diltiazem hydrochloride in patients with mild to moderate hypertension.
    Hollifield JW; Heusner JJ; DesChamps M; Gray J; Spyker DA; Peace KE; Dickson B
    Clin Pharm; 1988 Feb; 7(2):129-34. PubMed ID: 3280220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrochlorothiazide and verapamil in the treatment of hypertension. The Verapamil Versus Diuretic (VERDI) Trial Research Group.
    Holzgreve H; Distler A; Michaelis J; Philipp T; Wellek S
    J Cardiovasc Pharmacol; 1991; 18 Suppl 6():S33-7. PubMed ID: 1725915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of verapamil SR, trandolapril, and their fixed combination on 24-h blood pressure: the Veratran Study.
    Veratran Study Group
    Am J Hypertens; 1997 May; 10(5 Pt 1):492-9. PubMed ID: 9160758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baroreceptor reflexes after coarctectomy.
    Hanson E; Eriksson BO; Sivertsson R
    Clin Physiol; 1981 Oct; 1(5):503-9. PubMed ID: 7199996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil.
    Houston MC; Weir M; Gray J; Ginsberg D; Szeto C; Kaihlenen PM; Sugimoto D; Runde M; Lefkowitz M
    Arch Intern Med; 1995 May; 155(10):1049-54. PubMed ID: 7748048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verapamil sustained-release in renal parenchymal hypertension: effect on blood pressure, kidney function, angiotensin II, aldosterone, arginine vasopressin, atrial natriuretic peptide, and lipoproteins.
    Eiskjaer H; Pedersen EB; Rasmussen LM; Jespersen B
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S17-22. PubMed ID: 2475677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of intravenous verapamil in arterial hypertension refractory to three-step antihypertensive therapy.
    Gurgenian SV; Mikaelian ES; Dzhandzhapanian AZ; Babaian AS
    Cor Vasa; 1991; 33(5):397-403. PubMed ID: 1810700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.